Lomustine and Intermediate Dose Cytarabine in Older Patients With AML

This study has been completed.

Sponsor:

Information provided by:

Groupe Ouest Est d'Etude des Leucémies et Autres Maladies du Sang GOELAMS

ClinicalTrials.gov Identifier:

NCT00480064

First received: May 29, 2007

Last updated: NA

Last verified: May 2007

History: No changes posted

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	May 2007
Estimated Primary Completion Date:	No date given